The upside case depends on converting technical milestones into repeatable on-prem and hybrid deployments with recurring software and services. The key risk is that proof of economic usefulness arrives too late to justify today’s expectations.

If Rigetti turns its chiplet-based superconducting roadmap into repeatable on-prem + hybrid deployments (with reliability/SLA productization), revenue can inflect into “infrastructure vendor” scale by 2031—enough to grow EV ~2x even if broad quantum advantage remains limited.

Quantum is a leveraged compute option in a world where cognition commoditizes; Rigetti’s upside is real, but gated by proof-of-utility and hard cryogenic scaling constraints.

Rigetti is priced as a long-dated compute option, so the 5-year outcome hinges on moving from “R&D vendor” to “deployable infrastructure”: shipping larger systems on-time, attaching recurring software/ops revenue (SLAs, hybrid orchestration), and widening distribution via sovereign/HPC channels. Compared with asset-light peers, Rigetti’s vertical integration can compound learning faster, but it also raises capital intensity and execution burden. My multiple assumes meaningful commercialization progress by 2031, but not a full mainstream breakthrough.

The two binding risks are (1) externally verifiable proof that Rigetti systems create economic value at scale, and (2) the physical scaling bottleneck of cryogenic infrastructure (cooling power, wiring heat-load, and fridge availability). Even if the roadmap advances, commercialization can lag, forcing dilution and potentially de-rating the stock.

$38.40